Early in the COVID-19 pandemic, researchers found that anticoagulation therapy was associated with improved survival among hospitalized COVID-19 patients. But many questions remained — about the size of the potential benefit, and about what dosage of this therapy might be more effective. New research suggests some possible answers.
Click here for original story, Additional data on blood thinner efficacy for COVID-19 and insight on best possible regimens
Source: ScienceDaily